You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent adult primary liver cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Active, not recruiting
  • Advanced Adult Primary Liver Cancer
  • +3 more
  • positron emission tomography
  • computed tomography
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +6 more
  • PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 21, 2022

Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary

Suspended
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • sorafenib tosylate
  • +2 more
  • Birmingham, Alabama
  • +20 more
Aug 29, 2022

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +2 more
  • sorafenib tosylate
  • stereotactic body radiation therapy
  • Berkeley, California
  • +50 more
Nov 17, 2022

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer

Recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • yttrium Y 90 glass microspheres
  • laboratory biomarker analysis
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 17, 2020

Recurrent Liver Cancer After Liver Transplantation Trial (Hepatic arterial infusion chemo + Atezolizumab and bevacizumab)

Not yet recruiting
  • Recurrent Liver Cancer After Liver Transplantation
  • Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab
  • (no location specified)
Apr 17, 2023

Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Recurrent Glioblastoma
  • Pitavastatin calcium
  • Rotterdam, Netherlands
    Erasmus MC
Aug 3, 2023

Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer Trial in Amsterdam (Neoadjuvant systemic therapy (CAPOX+/-B

Recruiting
  • Colorectal Cancer
  • +5 more
  • Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
  • Repeat local treatment
  • Amsterdam, Netherlands
    Amsterdam UMC
May 5, 2023

Primary Liver Cancer Early Detection

Recruiting
  • Liver Cancer
  • Liver-cancer early detection test
  • Changchun, Jilin, China
  • +1 more
Aug 10, 2023

Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))

Not yet recruiting
  • Colon Cancer Liver Metastases
  • sequential adult left lateral lobe liver transplantation (SALT)
  • (no location specified)
Oct 3, 2023

Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )

Not yet recruiting
  • Primary Biliary Cholangitis (PBC)
  • (no location specified)
Aug 29, 2023

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Liver Transplant Disorder, Hepatic Cancer Trial (assisted liver transplantation combined with two-stage hepatectomy)

Not yet recruiting
  • Liver Transplant Disorder
  • Hepatic Cancer
  • assisted liver transplantation combined with two-stage hepatectomy
  • (no location specified)
Mar 6, 2023

Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Liver, Cancer of, Primary Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Jan 18, 2023

Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Hepatocellular Carcinoma Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Mar 1, 2023

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Primary Liver Cancer Trial in Shanghai (Embosphere and chemo drug, Polyvinyl alcohol embolization microspheres (Huihe Medical)

Enrolling by invitation
  • Primary Liver Cancer
  • Embosphere and chemotherapy drug
  • Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug
  • Shanghai, Shanghai, China
    Shanghai Huihe Healthcare Tecnology Co.,Ltd.
Mar 5, 2023

Safety of Niraparib in Korean Primary and Recurrent Epithelial

Completed
  • Epithelial Ovarian Cancer
  • Seoul, Korea, Republic of
    Department of Obstetrics and Gynecology, University of Ulsan Col
Oct 11, 2023

Cancer, Solid Tumor, Ovarian Cancer Trial in Minneapolis (FT538, Enoblituzumab)

Not yet recruiting
  • Cancer
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center - University of Minnesota
Jan 24, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma Trial in

Completed
Has Results
  • Adult Hepatocellular Carcinoma
  • +3 more
  • Stereotactic Radiosurgery
  • Bronx, New York
    Albert Einstein College of Medicine
Dec 6, 2021

Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)

Not yet recruiting
  • Liver Metastases
  • +3 more
  • PVE
  • +2 more
  • Warsaw, Mazowieckie, Poland
    Second Department of Clinical Radiology
Sep 17, 2023

Detect and Expunge Concealed Tumors of the Liver

Recruiting
  • Liver Cancer
    • Hanoi, Vietnam
      108 Military Central Hospital
    Nov 15, 2023

    Colorectal Liver Metastasis Trial in Shanghai (HAIC-FOLFOX combined with Sintilimab and Regorafenib)

    Recruiting
    • Colorectal Liver Metastasis
    • HAIC-FOLFOX combined with Sintilimab and Regorafenib
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 1, 2023

    Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

    Recruiting
    • Melanoma
    • +14 more
    • LITT + Pembrolizumab
    • Gainesville, Florida
    • +1 more
    Aug 22, 2022